High Glucose Aggravates Cerebral Ischemia/Reperfusion via Truncated NLRP3 ‐Mediated Hexokinase‐2 Translocation
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70660 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Hengchang Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Hexokinase, Reperfusion Injury, Glucose. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Innovation Program of Hunan Province, Hunan Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Background
High blood glucose is a well‐established risk factor for poor outcomes in ischemic stroke. However, the underlying molecular mechanisms linking high blood glucose to worsened stroke outcomes remain unclear.
Objectives
Previous studies have implicated the NLRP3 inflammasome, a key mediator of neuroinflammation, in cerebral ischemia/reperfusion (I/R) injury. Under high blood glucose conditions, NLRP3 activation is amplified, potentially driving a vicious cycle of inflammation and neuronal death. Yet, how high blood glucose specifically modulates NLRP3 activation and its downstream pathways remains unclear. This study aimed to investigate the specific mechanisms by which high glucose enhances NLRP3 inflammasome activity and contributes to worsened brain injury following cerebral I/R.
Methods
We employed a combination of in vitro and in vivo experimental approaches to explore the impact of high glucose on NLRP3 inflammasome activation and its consequences on ischemic stroke outcomes. In vitro experiments were conducted by culturing various immune cells in high‐glucose conditions to evaluate the activation of the NLRP3 inflammasome and the mitochondrial association of HK2. In vivo, mice with genetic knockouts of Nlrp3 , Pycard (the gene encoding ASC), or microglial‐specific Hk2 were subjected to transient middle cerebral artery occlusion (tMCAO).
Results
Our findings revealed that the activation of the NLRP3 inflammasome was enhanced post cerebral I/R under high glucose and a N‐terminal truncation of NLRP3 (miniNLRP3) was induced. Overexpression of PKA could promote the generation of miniNLRP3, while inhibition of PKA decreased the generation of miniNLRP3. In addition, treatment with pan serine protease could block PKA and LPS mediated generation of miniNLRP3. Overexpression of the N‐terminal truncation of NLRP3 could potentiate the activation of the NLRP3 inflammasome under high glucose conditions by promoting the dissociation of Hexokinase 2 (HK2) from mitochondria. In addition, knockout of Nlrp3 , Pycard , or microglial Hk2 , could all attenuate cerebral I/R‐induced brain injury under high blood glucose in mice.
Conclusion
Our study elucidates PKA‐mediated generation of a 30 kD N‐terminal truncation of NLRP3 (miniNLRP3) in a serine protease‐dependent manner, which could potentiate the activation of the NLRP3 inflammasome under high glucose conditions via promoting the dissociation of HK2 from mitochondria. These findings add a new dimension to our understanding of NLRP3 regulation in the context of stroke injury, and suggest that the PKA‐miniNLRP3‐HK2‐NLRP3 pathway is a promising therapeutic strategy to improve stroke outcomes in patients with elevated blood glucose levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
- Key Laboratory of Clinical Neurology (Hebei Medical University), Ministry of Education, Shijiazhuang, Hebei, China.
- Department of Anesthesiology, The People's Hospital of Longhua Shenzhen, Affiliated Longhua People's Hospital, Southern Medicine University, Shenzhen, China.
- The Brain Science Center, Beijing Institute of Basic Medical Sciences, Beijing, China.
- The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine/Research Center of Neurobiology, Shanxi University of…
- NHC Key Laboratory of Neurodegenerative Diseases (University of South China), Hengyang, China.
ORCID-Profile: Ruoyi Guo, Yajin Liao
Förderung
- National Natural Science Foundation of China
- Science and Technology Innovation Program of Hunan Province
- Hunan Provincial Natural Science Foundation of China
- University of South China Clinical Research 4310 Program
- Clinical Medical Research Center of Hunan Province
- Foundation of Hunan Provincial Key Laboratory
Zitieren
APA
Zhang, H., Guo, R., Li, X., Zhang, Y., Zhou, L., Wang, J., Huang, Y., Yuan, Z., Song, L., & Liao, Y. (2025). High Glucose Aggravates Cerebral Ischemia/Reperfusion via Truncated NLRP3 ‐Mediated Hexokinase‐2 Translocation. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70660
Vancouver
Zhang H, Guo R, Li X, Zhang Y, Zhou L, Wang J, et al. High Glucose Aggravates Cerebral Ischemia/Reperfusion via Truncated NLRP3 ‐Mediated Hexokinase‐2 Translocation. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70660
BibTeX
@article{Zhang2025,
author = {Zhang, Hengchang and Guo, Ruoyi and Li, Xiang and Zhang, Yang and Zhou, Lujun and Wang, Junjie and Huang, Yudi and Yuan, Zengqiang and Song, Lijuan and Liao, Yajin},
title = {High Glucose Aggravates Cerebral Ischemia/Reperfusion via Truncated NLRP3 ‐Mediated Hexokinase‐2 Translocation},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70660}
}
EUVIMED